col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


61 Ergebisse       Seite 1

 [1] 
Elsevier: Immunobiology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Nov―07 Predictive value of NKG2A+ NK cell population in diagnosing severe COVID-19 patients Yang Chunqiu, Qian Rui, Gong Mengtao, Qin Yizu, Zheng Meijuan
2 [GO] 2025―Okt―03 Specific human antibodies against SARS-CoV-2 and monkeypox virus generated via a rapid construction and screening system Guanglei Gu, Jinhai Wang, Xiaoyun Hu, Xiuling Gu, Shirui Li, Hanle Li, Min Fang
3 [GO] 2025―Aug―09 Complement expression determines disease severity in mouse models of SARS-CoV-2 and influenza pneumonia Peter Szachowicz, Alexander Watson, Christine Wohlford-Lenane, Boopathi Sownthirarajan, Jeffery Dubert, Yuzhou Zhang, et al. (+3)
4 [GO] 2025―Aug―09 MicroRNA sequencing of plasma exosomes reveals complement dysregulation in COVID-19 Anthony Shadid, Aleksey Domozhirov, Lavanya Gunamalai, Scott Collum, Galina Florova, Andrey Komissarov, et al. (+4)
5 [GO] 2025―Aug―09 Complement C9-mediated RBC hemolysis drives microvascular obstruction via endothelial necroptosis and hemolyzed RBC aggregation in COVID-19 Chia Lun (Mike) Wu, Lining Arnold Ju, Ethan Italiano, Rocko Jarvis-Child, Imala Alwis, Rhyll Smythe, et al. (+18)
6 [GO] 2025―Aug―09 Complement activation and immune responses induced by Nuvaxovid and ChAdOx1 vaccines against Covid-19 Eija Nissilae, Tommaso Poletto, Elias Aho, Gabriele Giudice, Juha Kotimaa, Karita Haapasalo, et al. (+2)
7 [GO] 2025―Mrz―30 Mechanism and Efficacy of Etanercept in Treating Autoimmune-like Manifestations of Coronavirus Disease 2019 in elderly individuals Lizhong Zhang, Hongyi Li, Lei Shi, Jie Geng, Haojun Zhang, Haoran Chen, et al. (+15)
8 [GO] 2024―Mai―24 Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 Laura Bergantini, Sara Gangi, Miriana d’Alessandro, Paolo Cameli, Beatrice Perea, Martina Meocci, et al. (+3)
9 [GO] 2024―Jan―28 Evaluation of the serum levels of CCL2, CCL3, and IL-29 after first and second administrations of the COVID-19 vaccine (Oxford-AstraZeneca) Zahra Bagheri-Hosseinabadi, Ayat Kaeidi, Mahdi Rezvani, Gholamhossein Taghipour Khaje Sharifi, Mitra Abbasifard
10 [GO] 2023―Okt―24 Comparable cytokine release ex-vivo by whole blood from COVID-19 patients with and without non-invasive ventilation Martina Bonacini, Ilaria Ferrigno, Alessandro Rossi, Nicola Facciolongo, Marco Massari, Romina Corsini, et al. (+4)
11 [GO] 2023―Sep―15 Levels of soluble TNF receptors (sTNFR1 and sTNFR2) increase with clinical worsening of patients and are related to COVID-19 mortality Melayne Rocha Aciole, Juliana Prado Gonçales, Patrícia Areias Feitosa Neves, Cynthia Regina Pedrosa Soares, Marta Iglis de Oliveira, Heloisa Ramos Lacerda de Melo, et al. (+4)
12 [GO] 2023―Sep―13 Targeting C5a is beneficial in critically ill COVID-19 patients Endry H.T. Lim, Alexander P.J. Vlaar, Matthijs C. Brouwer, Diederik van de Beek
13 [GO] 2023―Aug―25 51 Activation of complement in a mouse model of severe COVID-19 Peter Szachowicz, Christine Wohlford-Lenane, Yuzhou Zhang, Paul McCray, Richard Smith
14 [GO] 2023―Aug―25 29 Humoral innate immunity and acute phase proteins in COVID-19 Cecilia Garlanda, Matteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, Francesco Scavello, Rosanna Asselta, et al. (+2)
15 [GO] 2023―Aug―25 87 Activation of complement pathways and formation of membrane attack complex contribute to the development of severe COVID-19 Calder Ellsworth, Zheng Chen, Joshua Currey, Mark Xiao, Alexis R. Katz, Chenxiao Wang, et al. (+6)
16 [GO] 2023―Aug―25 96 Association between acute stage biomarker levels, severity and long-term outcome in COVID-19 Lisa Hurler, Federica Mescia, Laura Bergamaschi, Erika Kajdácsi, György Sinkovits, László Cervenak, et al. (+3)
17 [GO] 2023―Aug―25 222 Complement Activation in Cytokine Storms Associated with COVID-19, Sepsis, and Chimeric Antigen Receptor (CAR)-T Therapy Ofer Perzon, Vernon VanHeerden, Avi Abutbol, Yehudit Shabat, Barak Reicher, Ivetta Danylesco, et al. (+2)
18 [GO] 2023―Aug―25 133 Complement system activation is mediated by COVID-19 severity, inducing endothelial cell injury and cell permeability Arlette Bohorquez-Hernandez, Niyousha Rostam, Claire Howard, Carolina G. Ortiz-Sandoval, Christopher J. Campbell, Christoph Licht
19 [GO] 2023―Aug―25 230 Interaction of factor H and factor H-related proteins with S and N proteins of SARS-CoV-2 Veronika H. Barbai, Alexandra Papp, Dániel Bencze, Barbara Uzonyi, Mihály Józsi
20 [GO] 2023―Aug―25 115 The mannose-binding lectin (MBL) in MIS-C: relationship between MBL genotype, levels, and functional activity against SARS-CoV-2 Matteo Stravalaci, Isabel Pagani, Hang Zhong, Marina Sironi, Simone Bondesan, Federica Barzaghi, et al. (+9)
21 [GO] 2023―Aug―25 169 Involvement of PTX3 and MBL in the clearance of SARS-CoV-2 infected lung airway epithelial cells Hang Zhong, Matteo Stravalaci, Isabel Pagani, Niloufar Kavian-Tessler, Barbara Bottazzi, Poli Guido, et al. (+2)
22 [GO] 2023―Aug―25 52 Human factor H and properdin modulate SARS-CoV-2 infection in a complement-independent manner Nazar Beirag, Praveen Varghese, Martin Mayora Neto, Robert Sim, Nigel Temperton, Uday Kishore
23 [GO] 2023―Aug―25 149 SARS-CoV-2 nucleocapsid protein is not responsible for the activation of complement lectin pathway Andrea Kocsis, Dalma Bartus, Péter Gál
24 [GO] 2023―Aug―25 84 Inhibition of SARS-CoV-2 spike interaction with angiotensin converting enzyme-2 (ACE2) by specific antibodies is enhanced by complement, determined with a novel flow cytometry assay Nikki McStraw, Elodie Lesne, Breeze Cavell, Stephaine Leung, Stephen Taylor, Andrew Gorringe
25 [GO] 2023―Aug―25 141 Characterization of the interaction of mannose-binding lectin with variant SARS-CoV-2 spike proteins Adrian Sutta, Beatriz González-García, Laura Pérez-Alós, Anne Rosbjerg, Peter Garred, Rafael Bayarri-Olmos
26 [GO] 2023―Aug―25 166 The complement system is dysregulated in long covid patients Kirsten Baillie, Sam Keat, Ermioni Melou, Kristen Ladell, Erik Toonen, Loek Willems, et al. (+4)
27 [GO] 2023―Aug―10 Tissue plasminogen activator receptor ANXA2 and its complementary regulator anti-inflammatory ANXA1 as prognostic indicators of inflammatory response in COVID-19 pathogenesis Rathika D. Shenoy, K.K. Nithin, M. Vijaykrishnaraj, Prakash Patil, K.J. Pavan, Dhananjay Alagundagi, Praveenkumar Shetty
28 [GO] 2023―Jul―28 Identification and Characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains Hannah Reimann, Carolin Moosmann, Kilian Schober, Vanessa Lang, Johan Verhagen, Julia Zeun, et al. (+4)
29 [GO] 2023―Jul―17 Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals Sheyda Houshmandfar, Ali Khodadadi, Mohammad-Reza Mahmoudian-Sani, Roohangiz Nashibi, Mohammad Rashno
30 [GO] 2023―Mai―30 Reduced susceptibility to COVID-19 associated with ABO blood group and pre-existing anti-A and anti-B antibodies Sharri Junadi Mortensen, Latika Anna Mikkelsen Gjerding, Mads Billeskov Exsteen, Thomas Benfield, Rune Larsen, Frederik Banch Clausen, et al. (+4)
31 [GO] 2023―Mai―11 Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know Wioleta M. Zelek, Richard A. Harrison
32 [GO] 2023―Mai―08 Flow cytometry profiling of cellular immune response in COVID-19 infected, recovered and vaccinated individuals Diksha Kumari, Sayar Singh, Manisha Kumari, Harshita Gupta, Deepika Chauhan, Karuna Singh, et al. (+12)
33 [GO] 2023―Apr―11 Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis Ashwini Shete, Supriya Deshpande, Jyoti Sawant, Nidhi Warthe, Madhuri Thakar, Manisha Madkaikar, et al. (+16)
34 [GO] 2023―Mrz―24 Th-1, Th-2, Th-9, Th-17, Th-22 type cytokine concentrations of critical COVID-19 patients after treatment with Remdesivir Kurosh kalantar, Atefe Ghamar Talepoor, Mahsa Eshkevar Vakili, Narges kaarami, Mehdi Kalani, Farzad Ghandehari, et al. (+3)
35 [GO] 2023―Feb―20 Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in urban Dhaka, Bangladesh Evana Akhtar, Akhirunnesa Mily, Protim Sarker, Bikash Chandra Chanda, Farjana Haque, Rakib Ullah Kuddusi, et al. (+4)
36 [GO] 2023―Feb―15 Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection Stefanos A. Tsiftsoglou, Eleni Gavriilaki, Tasoula Touloumenidou, Evaggelia-Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, et al. (+18)
37 [GO] 2023―Feb―11 Study of Some Immunological Signatures and their Association with COVID-19 in a Sample of Recovered Iraqi Patients Fadia M. Maki, Amina N. AL-Thwani, Kareem S. Jiad
38 [GO] 2023―Jan―27 MicroRNA-155 and 194 alter expression of Th17 and T regulatory-related transcription factors in the patients with severe coronavirus disease 2019 (COVID-19) Asieh Asadpour-Behzadi, Ashraf Kariminik, Babak Kheirkhah
39 [GO] 2022―Nov―24 CD4 and IL-2 Mediated NK Cell Responses after COVID-19 Infection and mRNA Vaccination in Adults Amir M. Alhajjat, Catherine R. Redden, Morgan Langereis, Steven T. Papastefan, Joy A.S. Ito, Katherine C. Ott, et al. (+3)
40 [GO] 2022―Nov―15 A Review on Structural, Non-structural, and Accessory Proteins of SARS-CoV-2: Highlighting Drug Target Sites Md. Jahirul Islam, Nafisa Nawal Islam, Md. Siddik Alom, Mahmuda Kabir, Mohammad A. Halim
41 [GO] 2022―Nov―09 Interleukin-38 promoter variants and risk of COVID-19 among Iraqis Ibtihal A. Al-Karaawi, Wasan W. Al-bassam, Haneen M. Ismaeel, Ali H. Ad'hiah
42 [GO] 2022―Okt―26 Genetic regulation of iron homeostasis in sideropenic patients with mild COVID-19 disease under a new oral iron formulation: lessons from a different perspective Giulio Giordano, Maria Teresa Bochicchio, Giovanna Niro, Alessandro Lucchesi, Mariasanta Napolitano
43 [GO] 2022―Okt―03 IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19 Alejandro Hernández-Solis, Azmavet M. Güemes-González, Ximena Ruiz-Gómez, Pablo Álvarez-Maldonado, Jessica Castañeda-Casimiro, Argelia Flores-López, et al. (+13)
44 [GO] 2022―Sep―28 Bioinformatics-based SARS-CoV-2 epitopes design and the impact of Spike protein mutants on epitope humoral immunities Qi Sun, Zhuan-qing Huang, Sen Yang, Yuan-yuan Li, Yue Ma, Fei Yang, et al. (+2)
45 [GO] 2022―Jul―06 The significance of antiglobulin (Coombs) test reactivity in patients with COVID-19 Wael Hafez, Mohamad Azzam Ziade, Arun Arya, Husam Saleh, Ahmed Abdelrahman
46 [GO] 2022―Jun―08 Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients Mouna BEN AZAIZ, Awatef BEN JEMAA, Walid SELLAMI, Chihebeddine ROMDHANI, Ridha OUSLATI, Hedi GHARSALLAH, et al. (+2)
47 [GO] 2022―Apr―12 Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives Bárbara Torres Rives, Yaíma Zúñiga Rosales, Minerva Mataran Valdés, Hilda Roblejo Balbuena, Goitybell Martínez Téllez, Jacqueline Rodríguez Pérez, et al. (+8)
48 [GO] 2022―Feb―04 Patients with moderate to severe COVID-19 have an impaired cytokine response with an exhausted and senescent immune phenotype Ashwin D. Dhanda, Dan Felmlee, Paula Boeira, Prebashan Moodley, Huey Tan, Leticia De Paula Scalioni, et al. (+3)
49 [GO] 2022―Feb―02 CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: influences of the disease severity and gender Mohsen Sharif zak, Mojtaba Abbasi-jorjandi, Gholamreza Asadikaram, Zohreh-al-sadat Ghoreshi, Mitra Rezazadeh-Jabalbarzi, Alireza afsharipur, et al. (+6)
50 [GO] 2021―Sep―24 MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19 Matthaios Speletas, Katerina Dadouli, Argyro Syrakouli, Nikolaos Gatselis, Georgios Germanidis, Varvara A. Mouchtouri, et al. (+13)
51 [GO] 2021―Aug―28 In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct Abhishek Sharma, Surinder Pal, Anil Panwar, Suresh Kumar, Ashok Kumar
52 [GO] 2021―Aug―17 Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection Juliana M. Serpeloni, Quirino Alves de Lima Neto, Léia Carolina Lucio, Anelisa Ramão, Jaqueline Carvalho de Oliveira, Daniela Fiori Gradia, et al. (+8)
53 [GO] 2021―Jul―13 Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development Tikam Chand Dakal
54 [GO] 2021―Mai―09 Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on Erythrocytes from ICU COVID-19 Patients Aymric Kisserli, Nathalie Schneider, Sandra Audonnet, Thierry Tabary, Antoine Goury, Joel Cousson, et al. (+5)
55 [GO] 2021―Jan―23 What do we know about the antibody responses to SARS-CoV-2? Francisco Alejandro Lagunas-Rangel, Venice Chávez-Valencia
56 [GO] 2020―Dez―24 BCG immunomodulation: from the ‘hygiene hypothesis’ to COVID-19 Aaron J. Moulson, Yossef Av-Gay
57 [GO] 2020―Nov―05 SARS-CoV-2 Attachment to Host Cells is Possibly Mediated via RGD-Integrin Interaction in a Calcium-dependent Manner and Suggests Pulmonary EDTA Chelation Therapy as a Novel Treatment for COVID 19 Tikam Chand Dakal
58 [GO] 2020―Nov―04 Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates Peter Arend
59 [GO] 2020―Aug―19 Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies Praveen Mathews Varghese, Anthony G. Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, et al. (+2)
60 [GO] 2020―Aug―09 Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, Marco Frigeni, Gianmaria Borleri, Anna Salvi, et al. (+11)
61 [GO] 2020―Mai―11 Immunoinformatics-guided designing of epitope-based subunit vaccine against the SARS Coronavirus-2 (SARS-CoV-2) Bishajit Sarkar, Md. Asad Ullah, Fatema Tuz Johora, Masuma Afrin Taniya, Yusha Araf
 [1] 

61 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec